IBCL-117 ASPEN: Long-Term Follow-Up Results of a Phase 3 Randomized Trial of Zanubrutinib vs Ibrutinib in Patients With Waldenström Macroglobulinemia

1. Castillo, J.J.
2. Tam, C.S.
3. Garcia-Sanz, R.
4. Opat, S.
5. D'Sa, S.
6. Jurczak, W.
7. Lee, H.-P.
8. Cull, G.
9. Owen, R.G.
10. Marlton, P.
11. Wahlin, B.E.
12. Tedeschi, A.
13. Siddiqi, T.
14. Buske, C.
15. Leblond, V.
16. Chan, W.Y.
17. Schneider, J.
18. Cohen, A.
19. Dimopoulos, M.